INFLUENCE OF PROTEIN-BINDING ON THE MYOCARDIAL UPTAKE AND PHARMACODYNAMICS OF PROPAFENONE

被引:23
作者
GILLIS, AM [1 ]
KATES, RE [1 ]
机构
[1] STANFORD UNIV,FALK CARDIOVASC RES CTR,SCH MED,DIV CARDIOL,STANFORD,CA 94305
关键词
D O I
10.1097/00005344-198611000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1163 / 1167
页数:5
相关论文
共 8 条
[1]   CLINICAL-PHARMACOLOGY OF PROPAFENONE [J].
CONNOLLY, SJ ;
KATES, RE ;
LEBSACK, CS ;
HARRISON, DC ;
WINKLE, RA .
CIRCULATION, 1983, 68 (03) :589-596
[2]  
GILLIS AM, 1986, J PHARMACOL EXP THER, V237, P708
[3]   BINDING OF ANTIARRHYTHMIC DRUGS TO PURIFIED HUMAN ALPHA-1-ACID GLYCOPROTEIN [J].
GILLIS, AM ;
YEE, YG ;
KATES, RE .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (24) :4279-4282
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF PROPAFENONE IN HUMAN-PLASMA SAMPLES [J].
HARAPAT, SR ;
KATES, RE .
JOURNAL OF CHROMATOGRAPHY, 1982, 230 (02) :448-453
[5]   PLASMA-LEVEL MONITORING OF ANTI-ARRHYTHMIC DRUGS [J].
KATES, RE .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (06) :C8-C13
[6]  
ROWLAND M, 1980, FRONTIERS THERAPEUTI, P27
[7]  
STEINBACH K, 1983, CARDIAC ARRHYTHMIAS, P141
[8]  
1972 P ONL INT C